Conviction
1 → 3
Conviction●●●○○3 of 5
Research target$159.44Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$37.93BSnapshot value
Research history
See all A changes ↗What changed
Target
— → $159.44
Thesis status
NEEDS_MORE_DATA → INTACT
Last reviewed
Not reviewed → 7/8/26
Target
— → $159.44
Conviction
1 → 3
Analytical instruments pure-play: LC/GC, mass spec, genomics reagents. Cleanest analytical exposure in Measure — less conglomerate dilution than TMO/DHR.
Biopharma R&D spending growth; companion diagnostics adoption; precision medicine driving instrument + consumable demand.
Research funding drag; academic budget pressure; China softness (significant APAC exposure); instrument cycle lumpiness.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Lean-Bull · ins-$0.2M · 13F 16+/8- · short↓0.3
Snapshot · 7/8/26